Erratum to: p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation (Oncogene, (2000), 19, 1, (51-60), 10.1038/sj.onc.1203231);p27(Kip1) accumulation is associated with retinoic-induced neuroblastoma differentiation: Evidence of a decreased proteasome-dependent degradation

Oncogene

Volumn 19, Issue 1, 2000, Pages 51-60

  Borriello, Adriana ^a   Della Pietra, Valentina ^a   Criscuolo, Maria ^a   Oliva, Adriana ^a   Tonini, Gian Paolo ^b   Iolascon, Achille ^c   Zappia, Vincenzo ^a   Della Ragione, Fulvio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Cyclin; Cyclin dependent kinase; Differentiation; Neuroblastoma; p27

Indexed keywords

CALPASTATIN; CYCLIN DEPENDENT KINASE; LACTACYSTIN; MESSENGER RNA; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P27; RECOMBINANT PROTEIN; RETINOBLASTOMA PROTEIN; RETINOIC ACID; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYSTEINE PROTEINASE; MICROTUBULE ASSOCIATED PROTEIN; MULTIENZYME COMPLEX; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; CELL CYCLE; CELL LINE; DRUG EFFECT; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYSTEINE ENDOPEPTIDASES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MULTIENZYME COMPLEXES; NEUROBLASTOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0034610545     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1203669     Document Type: Erratum

References (32)

1. Alessandrini A, Chiaur DS and Pagano M. (1997). Leukemia, 11, 342-347.
2. Chomczynski P and Sacchi N. (1987). Analytical Biochem., 162, 156-159.
3. Coats S, Flanagan WM, Nourse J and Roberts JM. (1996). Science, 272, 877-880.
4. Della Ragione F, Russo GL, Oliva A, Mastropietro S, Mancini A, Borrelli A, Casero RA, Iolascon A and Zappia V. (1995). Oncogene, 10, 827-835.
5. Della Ragione F, Russo GL, Oliva A, Mercurio C, Mastropietro S, Della Pietra V and Zappia V. (1996). J. Biol. Chem., 271, 15942-15949.
6. Dongming S, Leung CL and Liem RKH. (1996). J. Biol. Chem., 271, 14245-14251.
7. Dulic V, Kaufmmann WK, Wilson AJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. (1994). Cell, 76, 1013-1023.
8. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 815-825.
9. Elledge SJ, Winson J and Harper JW. (1996). Trends Cell Biol., 6, 388-392.
10. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge S. (1993). Cell, 75, 805-816.
11. Hengst L, Dulic V, Slingerland JM, Lees E and Reed SI. (1994). Proc. Natl. Acad. Sci. USA, 91, 5291-5295.
12. Hengst L and Reed SI. (1996). Science, 271, 1861-1864.
13. Iolascon A, Giordani L, Moretti A, Tonini GP, Lo Cunsolo C, Mastropietro S, Borriello A and Della Ragione F. (1998). Pediatric Res., 43, 139-144.
14. Kato JY, Matsuoka M, Polyak K, Massague J and Sherr CJ. (1994). Cell, 79, 487-496.
15. Khan AA, Villablanca JG, Reynolds CP and Avramis VI. (1996). Cancer Chemo. Pharmacol., 39, 34-41.
16. Lee M-H, Reynisdottir I and Massague J. (1995). Genes Dev., 9, 639-649.
17. Liu M, Lee M-H, Cohen M, Bommakanti M and Freedman LP. (1996). Genes Dev., 10, 142-153.
18. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M. (1997). Nature Med., 3, 231-236.
19. Murakami T, Ohmori H, Tsuda T and Higashi K. (1991). Progr. Clin. Biol. Res., 366, 65-70.
20. Nicoletti I, Migliorati G, Pagliacci MC, Grignai F and Riccardi C. (1991). J. Immunol. Met., 139, 271-279.
21. Pagano M, Tam SW, Theodoras AM, Beer RP, Del SG, Chau V, Yew PR, Draetta GF and Rolfe M. (1995). Science, 269, 682-685.
22. Philip T and Pinkerton CR. (1989). In: New Direction in Cancer Treatment. Magrath J. (ed.). Springer: Heidelberg. Germany, pp. 605-611.
23. Pinkerton CR. (1993). In: Human Neuroblastoma: Recent Advances in Clinical and Genetics Analysis. Schwab M, Tonini GP and Benard J. (eds). Harwood Academic Publications: Chur, Switzerland, pp. 3-10.
24. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. (1994b). Genes Dev., 8, 9-22.
25. Sheaff RJ, Groudine M, Gordon M, Roberts JM and Clurman BE. (1997). Genes Dev., 11, 1464-1470.
26. Sherr CJ. (1994). Cell, 79, 551-555.
27. Thiele CJ, Reynolds CP and Israel MA. (1985). Nature, 313, 404-406.
28. Timchenko NA, Wilde N, Nakanishi M, Smith JR and Darlington GJ. (1996). Genes Dev., 10, 804-815.
29. Toyoshima H and Hunter T. (1994). Cell, 78, 67-74.
30. Vlach J, Hennecke S, Alevizopoulos K, Conti D and Amati B. (1996). EMBO J., 15, 6595-6604.
31. Vlach J, Hennecke S and Amati B. (1997). EMBO J., 16, 5334-5344.
32. Zancai P, Cariati R, Rizzo S, Baiocchi M and Dolcetti R (1998). Oncogene 17, 1827-1836.